BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 35, Issue 1, Pages 223-231
Publisher
Wiley
Online
2014-07-29
DOI
10.1111/liv.12649
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemoembolization and Radioembolization for Hepatocellular Carcinoma
- (2013) Riad Salem et al. Clinical Gastroenterology and Hepatology
- Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma
- (2013) Luigi Bolondi et al. DIGESTIVE AND LIVER DISEASE
- Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) C. Verslype et al. ANNALS OF ONCOLOGY
- Improved Time to Progression for Transarterial Chemoembolization Compared With Transarterial Embolization for Patients With Unresectable Hepatocellular Carcinoma
- (2012) Michael A. Morse et al. Clinical Colorectal Cancer
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2012) EUROPEAN JOURNAL OF CANCER
- Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
- (2012) Marta Burrel et al. JOURNAL OF HEPATOLOGY
- Prognosis of Hepatocellular Carcinoma in Relation to Treatment Across BCLC Stages
- (2011) Delia D’Avola et al. ANNALS OF SURGICAL ONCOLOGY
- Liver transplantation for hepatocellular carcinoma in clinical practice
- (2011) Fabio Farinati et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma
- (2011) Timothy M. Pawlik et al. JOURNAL OF CLINICAL ONCOLOGY
- Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
- (2010) J.-L. Raoul et al. CANCER TREATMENT REVIEWS
- Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study
- (2009) Fabio Farinati et al. BMC CANCER
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma
- (2009) M. MABED et al. EUROPEAN JOURNAL OF CANCER CARE
- Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes
- (2009) Riad Salem et al. GASTROENTEROLOGY
- The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma – Survival analysis of 3892 patients
- (2008) Jing-Houng Wang et al. EUROPEAN JOURNAL OF CANCER
- Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402)
- (2008) M. Doffoël et al. EUROPEAN JOURNAL OF CANCER
- Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead™
- (2008) Katerina Malagari Expert Review of Anticancer Therapy
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started